News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FINOX Biotech And Save The Children Switzerland Announce 0.12CHF (€0.10) Will Be Donated For Every Bemfola® Product Leaving The Swiss Factory.


7/3/2014 8:58:44 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Finox Biotech (Finox AG) and Save the Children Switzerland announced today a wide ranging collaboration including the agreement that for every Bemfola® product leaving the Swiss factory 0.12CHF (€0.10) will be donated to Save the Children Switzerland for their charity projects across the world.

The donation is part of Finox Biotech’s wide ranging corporate social responsibility program. Amongst other activities it is planned that executives and employees of Finox Biotech will undertake field visits to Save the Children projects across the world.

Gavin Jelic-Masterton, Chief Executive of Finox Biotech commented, “it is very exciting for us at Finox Biotech to be able to announce this important collaboration. We are in the business of helping couples to become parents, and we know that those couples will be thrilled to know that we as a company will be giving something back to disadvantaged children across the world as a result of their treatment. As a company we believe in the values that define Save the Children Switzerland and their commitment to improving children’s lives through health, famine relief, education, child protection, and emergency aid projects.”

Jérôme Strijbis, CEO of Save the Children Switzerland added “We at Save the Children Switzerland are very grateful to be able to count on the support of Finox Biotech in the future. For us the needs of children — whether it's clean water, access to health care and education or relief after an emergency or natural disaster — are the number one priority. Through Finox Biotech alignment with us, we will be able to further transform children’s lives, changing the course of their futures and making the world a better place for everybody.”

About Finox Biotech
Finox Biotech (FINOX AG) is a biopharmaceutical company with its corporate headquarters in Burgdorf, Switzerland. Finox’ first product is BEMFOLA®, a biosimilar r-FSH of GONAL-f®. Finox Biotech was founded in 2007 with a vision to become a leading company in the field of fertility therapies, by combining high quality Swiss medicines with innovative, award-winning delivery devices.

For further information please visit www.finoxbiotech.com or contact us at: info@finoxbiotech.com / +41 (0)34 426 11 11, Finox Biotech Technikumstrasse 2, 3401 Burgdorf, Switzerland

About Save the Children Switzerland
Save the Children is the world’s leading independent organisation for children. Save the Children has been advocating for children’s rights in Switzerland since 2006 and works in over 120 countries.

We work in the fields of health and survival, school and education and protection from exploitation and violence. We also support children and their families in situations of emergencies. Save the Children has consultative status with the United Nations Economic and Social Council (ECOSOC).

For further information please contact Sarah Frattaroli, Junior Project Manager Communications, sarah.frattaroli@savethechildren.ch, +41 44 267 74 85 www.savethechildren.ch

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES